Shawn Kwatra, MD, discusses the effects of poorly controlled or severe atopic dermatitis on patients’ quality of life and how to measure patient-reported outcomes.
Video content above is prompted by the following questions:
What are the effects of poorly controlled/severe atopic dermatitis (AD) on patient’s quality of life (QoL)?
In your clinical experience, which patient-reported outcome (PRO) in AD most impacts patients’ quality of life? (Itch control, skin appearance, sleep improvement, others)?
How do you measure PRO outcomes in your clinical practice?
How often is treatment satisfaction influenced by achievement of PRO targets?